ARTBIO

Q: What is ARTBIO's official website?

ARTBIO's official website is www.artbio.com

Q: What is ARTBIO's Revenue?

ARTBIO's revenue is $16.9 Million

Q: What industry does ARTBIO belong to?

ARTBIO is in the industry of: Manufacturing , Pharmaceuticals , Business Services

Q: What is ARTBIO competition?

ARTBIO top competitors include: Tae-Hunn Lee , Darrasphysio , Singula Bio , PallCHASE

Q: What technology does ARTBIO use?

Some of the popular technologies that ARTBIO uses are: Google AdSense, Google Universal Analytics, Google Tag Manager, Google Analytics

Q: What are ARTBIO social media links?

ARTBIO Linkedin page ARTBIO Twitter page

Q: Who invested in ARTBIO?

ARTBIO has 11 investors including F-Prime Capital Partners, Omega Fund Management, Third Rock Ventures and F-Prime Capital Partners.

Q: Is ARTBIO a public company?

ARTBIO is private company therefore does not currently have an official ticker symbol

Manufacturing · Massachusetts, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

1 Kendall Sq B200 Ste 001, Cambridge, Ma...

Website

www.artbio.com

Revenue

$16.9 Million

Industry

Manufacturing

Pharmaceuticals

Business Services

Research & Development

ZI Rank: 1

Signal Type

Dec

Jan

Feb

Mar

Apr

May

ZI Rank

About ARTBIO

ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. The company is headquartered in Cambridge, Massachusetts.Explore more

Is this data correct?

View contact profiles from ARTBIO

Popular SearchesArtbioARTBIO IncArtbio AsARTBIO'sSIC Code 28,283NAICS Code 32,325Show more

ARTBIO Org Chart

Phone

Nikki Hadas

Chief Legal Officer

Phone

Margaret Yu

Chief Medical Officer

Phone

Get the full picture

Victor Paulus

Senior VP & Head of Regulatory Affairs

Phone

Get the full picture

Is ARTBIO your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Website visits: Recent activity has been detected on your website

Congratulate Masked Content for being promoted to Masked Content at ARTBIO

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Earning: See what the market has to say on ARTBIO recently announced quarterly report

ARTBIO, which may be a good buyer, showed buying intent in Masked Content Topic

Check if ARTBIO has recently received funding, and reach out quickly before it becomes old news!

Click to see if ARTBIO had a recent Job posting/layoffs

Product Launch: Get notified when ARTBIO launches new products

Funding: Get notified immidiatlly once ARTBIO has new funding data

Check out if ARTBIO is spiking on competitors!

Recommended Actions

Introduce yourself to Masked Content, who has shown a strong intent to purchase lately

Find more new buyers

Compare Similar Companies to ARTBIO

Compare insights from companies similar to ARTBIO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

ARTBIO

$16.9M

51-200

Private

$245M

2021

Nikki HadasChief Legal Officer

PallCHASE

<$5M

1-10

Private

N/A

Darrasphysio

<$5M

11-50

Private

N/A

Singula Bio

<$5M

1-10

Private

N/A

Tae-Hunn Lee

<$5M

1-10

Private

N/A

BeroiaMed

<$5M

1-10

Private

N/A

View Email Formats for ARTBIO

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

ARTBIO is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

ARTBIO is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ARTBIO.

ARTBIO financials insights

Gather financial insights about ARTBIO, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2023

Angel/Seed

$23M

Series A

$90M

2025

Series B

$132M

See All ARTBIO's Financials Insights

ARTBIO Tech Stack

A closer look at the technologies used by ARTBIO

Google AdSense

Google

Google Universal Analytics

See more technologies

Most Recent Scoops

New Hire

Executive Move

Jonathan Freeman has joined the organization as Chief Business Officer. Previously Freeman served as Co-founder & Chief Operating Officer for Anthos Therapeutics.

Executive Moves, New Hire

Funding

ARTBIO has secured $132 million in Series B funding. The round was led by investors Sofinnova Investments and B Capital, with participation from F-Prime, Omega Funds, and Third Rock Ventures.

Funding

New Hire

Executive Move

ARTBIO has announced that Margaret Yu has joined the organization as Chief Medical Officer. Previously Yu served as Vice President, Integration and Asset Externalization Lead for Johnson & Johnson Innovative Medicine.

Executive Moves, New Hire

Open Position

ARTBIO is currently seeking a Senior Director, Clinical Imaging. (Cambridge, Massachusetts, United States)

Open Position

See more scoops

ARTBIO News & Media

ARTBIO Announces Dosing of Two Cohorts with AB001 in ARTISAN, a Phase 1 Alpha Radioligand Therapy Clinical Trial for Metastatic Castration Resistant Prostate Cancer
The ARTISAN trial is assessing the safety and anti-tumor activity of lead asset AB001 in patients with metastatic castration-resistant prostate cancer (mCRPC) Two cohorts, 177Lu-PSMA naïve patients and 177Lu-PSMA experienced patients, have been dosed in line with study protocol CAMBRIDGE,...
www.prnewswire.com
Industry Veteran Jonathan Freeman, Ph.D. Joins ARTBIO As Chief Business Officer
Appointment reflects Company's expanding operations as a clinical-stage biotech following steady growth in 2025 Dr. Freeman will shape corporate business development and strategic partnerships CAMBRIDGE, Mass., Jan. 6, 2026 /PRNewswire/ -- ARTBIO, Inc. ("ARTBIO"), a clinical-stage...
www.prnewswire.com
ARTBIO Announces FDA Clearance of IND Application for Lead Alpha Radioligand Therapy AB001
ARTBIO is developing AB001, a Pb212 prostate-specific membrane antigen (PSMA)-targeted radioligand therapy, for the treatment of metastatic castration resistant prostate cancer (mCRPC) Clinical studies will initiate in the U.S. and additional geographies are under consideration CAMBRIDGE,...
www.prnewswire.com
ARTBIO Expands Board of Directors with Four New Appointments; Co-Founder Shifts to ...
www.citybiz.co
ARTBIO Appoints Four New Board Members, Co-Founder Transitions to Technical Advisory Board Role
Appointments reflect ARTBIO's commitment to utilizing world-class experience and insights needed to advance alpha radioligand programs Company Co-founder Roy Larsen, Ph.D. will transition from Board of Directors to a new Technical Advisory Board within ARTBIO CAMBRIDGE, Mass., Aug. 7,...
www.prnewswire.com

Top Manufacturing Companies

Frequently Asked Questions Regarding ARTBIO

What is ARTBIO's official website?

ARTBIO's official website is www.artbio.com

What is ARTBIO's Revenue?

ARTBIO's revenue is $16.9 Million

What is ARTBIO's SIC code?

ARTBIO's SIC: 28,283

What is ARTBIO's NAICS code?

ARTBIO's NAICS: 32,325

How many employees does ARTBIO have?

ARTBIO has 51-200 employees

What industry does ARTBIO belong to?

ARTBIO is in the industry of: Manufacturing, Pharmaceuticals, Business Services

What is ARTBIO competition?

ARTBIO top competitors include: Tae-Hunn Lee, Darrasphysio, Singula Bio, PallCHASE

What technology does ARTBIO use?

Some of the popular technologies that ARTBIO uses are: Google AdSense, Google Universal Analytics, Google Tag Manager, Google Analytics

What does ARTBIO do?

What are ARTBIO social media links?

ARTBIO Linkedin page ARTBIO Twitter page

Who invested in ARTBIO?

ARTBIO has 11 investors including F-Prime Capital Partners, Omega Fund Management, Third Rock Ventures and F-Prime Capital Partners.

Is ARTBIO a public company?

ARTBIO is private company therefore does not currently have an official ticker symbol

See more information about ARTBIO

ARTBIO Latest Hires and Their Positions

ARTBIO is expanding and recently hired new employees. Here are the latest additions to the team.

Pauline Gad

Strategy and Operations Intern

Joined Feb 1, 2026

Phone

Jonathan Freeman

Chief Business Officer

Joined Jan 1, 2026

Phone

Francis Payumo

Head Senior Director, Clinical Operations

Joined Oct 1, 2025

Phone

Sean Daley

Legal Intern

Joined Sep 1, 2025

Phone

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.